Olanzapine-Induced Hypertriglyceridemia Resulting in Necrotizing Pancreatitis.
Olanzapine is an atypical antipsychotic agent that was approved by the Food and Drug Administration in 1996 for treatment of psychotic disorders, bipolar disorder, and schizophrenia. Since that time, numerous case reports have been published that describe the association of olanzapine and the development of pancreatitis. Furthermore, 3 reports suggest the mechanism of olanzapine-induced hypertriglyceridemia as the etiology of this progression. We report a case of a 36-year-old man who developed necrotizing pancreatitis secondary to olanzapine-induced hypertriglyceridemia. This case, to our knowledge, is the most severe case of this progression and the first case requiring plasmapheresis for acute management.
University of Cincinnati College of Medicine, Cincinnati, OH.
Samantha M
SM
Buszek
Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH.
Prabir
P
Roy-Chaudhury
Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH.
Ganesh
G
Yadlapalli